Back to search

University of British Columbia

The impact of disease-modifying drugs for multiple sclerosis on hospitalizations and mortality in British Columbia : a retrospective study using an illness-death multi-state model

Abstract

dc:description

Multiple sclerosis (MS) is an autoimmune disease that progresses over the course of years. MS is treated with disease-modifying drugs (DMDs). The efficacy of DMDs was established in clinical trials that were short and excluded older individuals and individuals living with comorbidities. This has led to a lack of knowledge of the effects of chronic DMD use and the effects of DMDs on individuals that do not meet the traditional eligibility criteria for clinical trials. This thesis applies multi-state models, which can advance the understanding of a disease beyond that offered by time-to-event models alone, to administrative healthcare data in a retrospective study to explore the long-term, real-world efficacy of DMDs. Chapter 2 applies time-to-event models and weighted cumulative exposure to explore the association between DMDs and mortality as well as to explore reverse causality. Chapters 3 and 4 implement an illness-death model to investigate the main research questions of this thesis: whether exposure to any DMD is associated with fewer hospitalizations, shorter hospitalizations, and/or a reduction in the chance of dying inside or outside the hospital. Specifically, in Chapter 3, Cox-type regressions estimate the hazard ratios (HRs) for exposure to any DMDs. In Chapter 4, pseudo-value regression models examine whether exposure is associated with more time spent alive and out of the hospital or more time hospitalized. Chapters 3 and 4 use interactions between DMD and comorbidity to analyze if the impact of DMDs changed across comorbidity burden. The change of the effects of exposure over time is also investigated in Chapters 2, 3, and 4. The results suggest that DMD use is initially associated with fewer hospitalizations but long-term DMD exposure is associated with more hospitalizations. Long-term DMD exposure is also associated with a greater hazard of dying outside the hospital. Pseudo-value regression suggested that exposure amongst individuals with high comorbidity burden is associated with more time spent alive and out of the hospital than it is for individuals with no comorbidity.

Degree

thesis:*
Name thesis:degree_name
Master of Science - MSc
Level thesis:degree_level
master's
Discipline thesis:degree_discipline
Statistics
Grantor dc:publisher
University of British Columbia
Year dc:date
2024

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Kempf, Graeme
Contributors dc:contributor
  • Petkau, A. John, 1950-
  • Zhao, Yinshan

Rights

dc:rights
Statement dc:rights
  • Attribution-NonCommercial-NoDerivatives 4.0 International
Language dc:language
eng

Identifiers

dc:identifier.*
Handle dc:identifier
http://hdl.handle.net/2429/89047

Chain of custody

source
Harvested from
University of British Columbia
Base URL
circle.library.ubc.ca/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Kempf, Graeme. The impact of disease-modifying drugs for multiple sclerosis on hospitalizations and mortality in British Columbia : a retrospective study using an illness-death multi-state model. master's thesis, University of British Columbia, 2024. http://hdl.handle.net/2429/89047